Rarity Bioscience Wins CYTO 2026 Innovation Technology Showcase with superRCA

Rarity Bioscience Wins CYTO 2026 Innovation Technology Showcase with superRCA

Rarity Bioscience has been named the winner of the CYTO 2026 Innovation Technology Showcase, organized by the International Society for Advancement of Cytometry (ISAC). The award recognizes superRCA, a technology that turns standard flow cytometers into ultra-sensitive molecular analyzers. The showcase lets early-stage companies present new technologies for cell analysis to cytometry experts, investors and […]

Rarity Bioscience Launches Ultra-Sensitive KIT D816V Assay, a New Benchmark for Molecular Testing in Systemic Mastocytosis

Ultra Sensitive superRCA KIT D816V Product release

Rarity Bioscience today announced the launch of the breakthrough superRCA Ultra-Sensitive KIT D816V Kit RUO, an ultra-sensitive assay for quantitative detection of the KIT D816V mutation. Developed in close collaboration with leading experts from Blueprint Medicines, a Sanofi company, and internationally recognized specialists in systemic mastocytosis (SM), the assay enables accurate and quantitative detection of […]

Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultra-Sensitive superRCA Assay

ARUP Laboratories Validates Rarity Bioscience superRCA

UPPSALA, SWEDEN, and SALT LAKE CITY (February 3, 2026) – Sweden-based Rarity Bioscience today announced that ARUP Laboratories, a leading national reference laboratory and nonprofit enterprise of the University of Utah, has become the first commercial laboratory in the United States to validate and offer its  groundbreaking superRCA™ assay for research applications.  Ultra-Sensitive superRCA™ Technology […]

Rarity Bioscience Expands into the United States

With a growing customer base in North America, Rarity Bioscience has now established a subsidiary, Rarity Bioscience Inc., incorporated in Delaware, USA — a key step in strengthening our international operations and supporting our North American customers and partners. This marks an important milestone in Rarity Bioscience’s international expansion and will serve as a strategic […]

Rarity Bioscience wins prestigious Disruptive Technology Award

ADLM Award winners

Rarity Bioscience has received the prestigious Disruptive Technology Award for its proprietary technology, superRCA™, which enables exceptionally sensitive detection of DNA mutations in common samples. The technology can detect a single mutation among 100,000 normal molecules – a capability that is critical for patients with cancer and other mutation-driven diseases, where early diagnosis, treatment monitoring, […]

Andrea Ballagi joins Rarity Bioscience

Andrea Ballagi New Member of the Board

We are delighted to welcome Dr. Andrea Ballagi to the board of Rarity Bioscience.  Dr. Ballagi brings extensive expertise in commercializing innovative biotechnological solutions. Her background uniquely combines both clinical and research perspectives — as a physician and a cancer researcher with a PhD.  Experience from Olink, Thermo Scientific, and IDEXX Laboratories Over the years, […]

Rarity Bioscience Partners with Beckman Coulter Life Sciences

We are proud to announce that Rarity Bioscience is partnering with Beckman Coulter Life Sciences – a collaboration that will elevate oncology research by making the superRCA technology accessible to a global audience. Expanding Flow Cytometry’s Capabilities Partnering with Beckman Coulter Life Sciences enables the global distribution of Rarity Bioscience’s ultra-sensitive superRCA assays, ensuring broader […]

Rarity Bioscience Launches Cutting-Edge superRCA Mutation Detection Kit

Rarity Bioscience NPM1 kit

Rarity Bioscience is thrilled to announce the release of its pioneering superRCA NPM1 Mutation Kit RUO™ and its universal Accessory Kit, designed to bring advanced mutation detection capabilities directly into your flow cytometry workflow. This innovative kit facilitates highly sensitive DNA based molecular analysis, delivering precise and quantitative Mutant Allele Frequency (MAF) in blood and […]

Nicolas Roelofs joins Rarity Bioscience

Nicolas Roelofs Joins rarity bioscience

Nick brings over 40 years of leadership in the life sciences tools and diagnostics industry, having shaped the strategic direction of companies like Agilent Technologies and Bio-Rad Laboratories. With deep expertise in chemistry, he served as President of Agilent’s Life Sciences Group, leading a $4 billion global business, including acquisitions such as Halo Genomics. At […]

Rarity Bioscience – Gold Sponsor at ESCCA 2024

Rarity Bioscience is Gold Sponsor at ESCCA 2024

We are excited to announce that Rarity Bioscience is a Gold Sponsor at the upcoming ESCCA 2024 Conference, reaffirming our commitment to advancing scientific cell analysis. The European Society for Clinical Cell Analysis (ESCCA) Conference is a leading event that unites top experts and researchers worldwide to discuss cutting-edge developments in flow cytometry and related technologies.

Gain access to our content!

Provide your email to get access to this, and all our other documents!

Thank you for submitting the form!

Download the document here

Now you can download any document on our website! 

Rarity Bioscience
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.